Investing in a healthier future: translational medicine at Imperial College London

Lan Zhao,Martin R Wilkins

转化医学研究 ›› 2014, Vol. 4 ›› Issue (3) : 31 -39.

PDF (5129KB)
转化医学研究 ›› 2014, Vol. 4 ›› Issue (3) : 31 -39. DOI: 10.3868/j.issn.2095-154X.2014.03.003EN
综述

Investing in a healthier future: translational medicine at Imperial College London

    Lan Zhao,Martin R Wilkins
作者信息 +

Investing in a healthier future: translational medicine at Imperial College London

Author information +
文章历史 +
PDF (5251K)

摘要

Clinical research is challenging.Recent recognition of the hurdles in translating discoveries in the laboratory into new medical treatments has galvanised stakeholders to co-ordinate their efforts to address the problems.In the UK,this has manifested itself as a major capital investment in infrastructure and the direction of research funds from government and charities into training researchers in experimental medicine and sponsoring strategic programmes of translational research.Support for collaborative programmes that enable deep-phenotyping of rare diseases,the development of biobanks for biomarker research and milestone-driven bench-to-bedside project grants are key examples of the new strategy.Imperial College London has been a beneficiary of the investment in translational medicine and provides here a snapshot of the developments and successes that have arisen and the prospects for the future.

关键词

stranslational medicine / experimental medicine / clinical research / training fellowships

Key words

引用本文

引用格式 ▾
Investing in a healthier future: translational medicine at Imperial College London[J]. 转化医学研究, 2014, 4(3): 31-39 DOI:10.3868/j.issn.2095-154X.2014.03.003EN

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

AI Summary AI Mindmap
PDF (5129KB)

275

访问

0

被引

详细

导航
相关文章

AI思维导图

/